Medicare Enrolled
Dr. Matthew Cotant, M.D.
Hematology & Oncology · Royal Oak, MI
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Cotant from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cotant?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Cotant
Dr. Matthew Cotant is a hematology & oncology specialist in Royal Oak, MI, with 19 years of NPI registration. Based on federal Medicare data, Dr. Cotant performed 122,690 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Cotant received a total of $14,183 from 86 pharmaceutical and/or device companies across 736 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Cotant is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 3% volume in MI
$14,183 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗122,690
Medicare services
Top 3% in MI for hematology & oncology
Not available
Unique patients (not deduplicated)
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
21,930 | $0 | $2 |
| Filgrastim injection (Nivestym) for white blood cells An injection of the biosimilar medication filgrastim-aafi (Nivestym) at a dose of 1 microgram. |
21,060 | $0 | $1 |
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
12,750 | $1 | $3 |
| Paclitaxel protein-bound particle injection An injection of paclitaxel formulated as protein-bound particles. This code specifies the administration of the medication measured in milligrams. |
10,200 | $10 | $29 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
9,700 | $0 | $6 |
| Pembrolizumab injection (Keytruda) | 8,800 | $43 | $105 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
7,950 | $0 | $5 |
| Daratumumab injection (Darzalex) An injection containing daratumumab and hyaluronidase-fihj administered under the skin. |
5,760 | $38 | $91 |
| Denosumab injection (Prolia/Xgeva) | 4,920 | $18 | $43 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
2,070 | $6 | $17 |
| Bortezomib injection, 0.1 mg Administration of a 0.1 mg dose of bortezomib medication via injection. |
1,890 | $3 | $50 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,530 | $1 | $40 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,516 | $8 | $11 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,474 | $8 | $25 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,126 | $0 | $1 |
| Injection, leucovorin calcium, per 50 mg | 889 | $3 | $30 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
840 | $6 | $17 |
| Injection, atropine sulfate, 0.01 mg | 800 | $0 | $1 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
613 | $96 | $265 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
559 | $2 | $10 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
519 | $69 | $186 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
458 | $12 | $40 |
| Phosphate level test A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong. |
334 | $5 | $10 |
| Liver function blood test panel | 333 | $8 | $17 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
332 | $6 | $13 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
332 | $102 | $276 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
331 | $4 | $10 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
330 | $11 | $37 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
329 | $8 | $17 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 327 | $3 | $22 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
212 | $137 | $369 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
198 | $7 | $14 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
195 | $2 | $6 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
190 | $64 | $146 |
| Anti-nausea injection (ondansetron/Zofran) | 148 | $0 | $10 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
146 | $1 | $2 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
145 | $10 | $22 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
122 | $51 | $134 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
120 | $7 | $20 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
117 | $57 | $153 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
107 | $23 | $59 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
92 | $1 | $4 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
91 | $23 | $61 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
82 | $141 | $397 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
75 | $1 | $3 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
68 | $51 | $136 |
| Prolonged intravenous chemotherapy administration This procedure involves the administration of chemotherapy medication directly into a vein over an extended period. |
65 | $99 | $270 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
60 | $25 | $95 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
59 | $28 | $79 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
57 | $10 | $40 |
| New patient office visit, complex (60-74 min) | 52 | $154 | $449 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
44 | $16 | $41 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
42 | $62 | $205 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
36 | $41 | $79 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
31 | $1 | $4 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
29 | $27 | $67 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
26 | $97 | $205 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
23 | $44 | $116 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
21 | $16 | $47 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
21 | $129 | $339 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
14 | $20 | $56 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
28.9% high complexity
65.5% medium
5.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$14,183
Total received (2018-2024)
Avg $2,026/year across 7 years
Top 13% in MI for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
86
Companies
736
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,993
2023
$3,148
2022
$2,015
2021
$777
2020
$728
2019
$2,029
2018
$1,493
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$1,382
Genentech USA, Inc.
$292
ABBVIE INC.
$160
Lilly USA, LLC
$156
Merck Sharp & Dohme LLC
$133
Janssen Biotech, Inc.
$126
Bayer Healthcare Pharmaceuticals Inc.
$112
Mirati Therapeutics, Inc.
$110
BeiGene USA, Inc.
$96
Gilead Sciences, Inc.
$95
EMD Serono, Inc.
$83
E.R. Squibb & Sons, L.L.C.
$81
Eisai Inc.
$78
Daiichi Sankyo Inc.
$68
AstraZeneca Pharmaceuticals LP
$66
TerSera Therapeutics LLC
$59
TAIHO ONCOLOGY, INC.
$57
Regeneron Healthcare Solutions, Inc.
$56
Agios Pharmaceuticals, Inc.
$54
Celgene Corporation
$48
PFIZER INC.
$48
ARRAY BIOPHARMA INC
$47
SERVIER PHARMACEUTICALS LLC
$46
Astellas Pharma US Inc
$46
Exelixis Inc.
$42
Sumitomo Pharma America, Inc.
$42
GlaxoSmithKline, LLC.
$40
Pharmacosmos Therapeutics Inc.
$40
Incyte Corporation
$30
Aveo Pharmaceuticals, Inc.
$29
Immunocore Limited
$26
Janssen Pharmaceuticals, Inc
$26
Acrotech Biopharma Inc.
$26
Octapharma USA, Inc.
$25
Tempus AI, Inc
$22
Rigel Pharmaceuticals, Inc.
$22
Ipsen Biopharmaceuticals, Inc
$21
Alexion Pharmaceuticals, Inc.
$20
GENZYME CORPORATION
$19
Stemline Therapeutics Inc.
$18
Genmab U.S., Inc.
$18
RECORDATI_RARE_DISEASES_INC.
$17
PUMA BIOTECHNOLOGY, INC.
$15
Top 3 companies account for 45.9% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$2,022
Genentech USA, Inc.
$1,046
Amgen Inc.
$867
AstraZeneca Pharmaceuticals LP
$797
PFIZER INC.
$676
Astellas Pharma US Inc
$590
E.R. Squibb & Sons, L.L.C.
$531
SANOFI-AVENTIS U.S. LLC
$484
Janssen Biotech, Inc.
$454
Lilly USA, LLC
$360
Merck Sharp & Dohme LLC
$325
GENZYME CORPORATION
$292
Gilead Sciences, Inc.
$282
Celgene Corporation
$280
Mirati Therapeutics, Inc.
$264
Exelixis Inc.
$231
Eisai Inc.
$215
EMD Serono, Inc.
$199
Seagen Inc.
$195
AMAG Pharmaceuticals, Inc.
$189
Bayer Healthcare Pharmaceuticals Inc.
$184
Janssen Pharmaceuticals, Inc
$183
EISAI INC.
$168
Daiichi Sankyo Inc.
$162
Merck Sharp & Dohme Corporation
$161
ABBVIE INC.
$160
Incyte Corporation
$147
Rigel Pharmaceuticals, Inc.
$147
BeiGene USA, Inc.
$135
Focal Therapeutics, Inc.
$129
ARRAY BIOPHARMA INC
$127
GlaxoSmithKline, LLC.
$126
Kite Pharma, Inc.
$105
TerSera Therapeutics LLC
$95
JAZZ PHARMACEUTICALS INC.
$94
Agios Pharmaceuticals, Inc.
$87
Regeneron Healthcare Solutions, Inc.
$79
SERVIER PHARMACEUTICALS LLC
$77
PharmaEssentia USA Corporation
$74
Takeda Pharmaceuticals U.S.A., Inc.
$64
SOBI, INC
$60
TAIHO ONCOLOGY, INC.
$57
Taiho Oncology, Inc.
$56
Sumitomo Pharma America, Inc.
$56
Ipsen Biopharmaceuticals, Inc
$52
G1 Therapeutics, Inc.
$50
Stemline Therapeutics Inc.
$50
Alexion Pharmaceuticals, Inc.
$46
MEDIVATION FIELD SOLUTIONS LLC
$45
AVEO Pharmaceuticals, Inc.
$45
Deciphera Pharmaceuticals Inc.
$43
Acrotech Biopharma Inc.
$43
Aveo Pharmaceuticals, Inc.
$42
Genmab U.S., Inc.
$42
Pharmacosmos Therapeutics Inc.
$40
Pharmacyclics LLC, an AbbVie Company
$38
PUMA BIOTECHNOLOGY, INC.
$36
AbbVie, Inc.
$32
Bayer HealthCare Pharmaceuticals Inc.
$32
Secura Bio, Inc.
$31
Karyopharm Therapeutics Inc.
$27
Puma Biotechnology, Inc.
$26
Immunocore Limited
$26
Shire North American Group Inc
$25
Octapharma USA, Inc.
$25
Myriad Genetic Laboratories, Inc.
$23
Foundation Medicine, Inc.
$23
Organon LLC
$22
Tempus AI, Inc
$22
Blue Earth Diagnostics Limited
$20
Kyowa Kirin, Inc.
$20
Sobi, Inc
$19
MorphoSys, US Inc.
$19
AbbVie Inc.
$18
Mylan Institutional Inc.
$18
Spectrum Pharmaceuticals Inc.
$17
Pharmacyclics LLC, An AbbVie Company
$17
RECORDATI_RARE_DISEASES_INC.
$17
Jazz Pharmaceuticals Inc.
$14
Myovant Sciences Inc.
$13
Seattle Genetics, Inc.
$13
Lexicon Pharmaceuticals, Inc.
$12
Coherus Biosciences Inc.
$12
Teva Pharmaceuticals USA, Inc.
$12
INSYS Therapeutics Inc
$12
Verastem, Inc.
$11
Top 3 companies account for 27.7% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · Alecensa · Avastin · Axumin · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · BioZorb · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CHANTIX · COPIKTRA · COSELA · CYRAMZA · Cabometyx · Columvi · Copiktra · Creon · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · EMPLICITI · ENJAYMO · EPKINLY · EXKIVITY · Enhertu · Epkinly · FARYDAK · FASLODEX · FERAHEME · FOTIVDA · FOUNDATIONONE · FULPHILA · GAZYVA · Gazyva · Halaven · Herceptin · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · INVOKANA · Imbruvica · Itovebi · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYRISK · NERLYNX · Neulasta · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Orserdu · PADCEV · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PYRUKYND · Padcev · Perjeta · Phesgo · Pomalyst · Prolia · QINLOCK · REBLOZYL · ROLVEDON · RYBREVANT · RYDAPT · Revlimid · Rezlidhia · Rituxan Hycela · SARCLISA · SCEMBLIX · SHINGRIX · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYLVANT · SYNDROS · Stivarga · TAGRISSO · TALZENNA · TASIGNA · TECENTRIQ · TECVAYLI · TEPMETKO · TEVIMBRA · TUKYSA · Tavalisse · Tazverik · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VOTRIENT · VPRIV · VYXEOS · Vectibix · Venclexta · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xermelo · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · Zoladex
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
121
County median income
$95,296
Nearest hospital to ZIP centroid (approximate)
BEAUMONT HOSPITAL ROYAL OAK
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Cotant is a mixed practice specialist, with above-average Medicare volume (top 3% in MI), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Cotant experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Cotant performed 21,930 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Cotant receive payments from pharmaceutical companies?
Yes. Dr. Cotant received a total of $14,183 from 86 companies across 736 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cotant's costs compare to other hematology & oncology specialists in Royal Oak?
Dr. Cotant's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cotant) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Royal Oak
Browse hematology & oncology specialists in Royal Oak ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in MI
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in MI
Which MI hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology